Literature DB >> 1755828

Alternative splicing of fibronectin: three variants, three functions.

J E Schwarzbauer1.   

Abstract

Fibronectin (FN) is a multi-functional extracellular matrix protein required for cell adhesion and migration, blood clotting, wound healing, and oncogenic transformation. The functional complexity is paralleled by structural diversity in that multiple forms of FN are generated by cell type-specific alternative splicing. In the rat, up to 12 different combinations of the three alternatively spliced segments (EIIIA, EIIIB, and the V region) are produced. What effects do these segments have on FN function? Recently, progress has been made in the identification of specific activities for the three variants of the V region, V120, V95, and V0. FN-mediated cell adhesion, FN synthesis and secretion, and incorporation into blood clots are differentially affected by these isoforms. These results suggest that cellular behavior is modulated by environmental cues provided by different types and proportions of alternatively spliced FN variants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755828     DOI: 10.1002/bies.950131006

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  40 in total

1.  Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.

Authors:  A A Rostagno; J E Schwarzbauer; L I Gold
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery.

Authors:  Kerstin Galler; Kerstin Junker; Marcus Franz; Julia Hentschel; Petra Richter; Mieczyslaw Gajda; Angela Göhlert; Ferdinand von Eggeling; Regine Heller; Raffaella Giavazzi; Dario Neri; Hartwig Kosmehl; Heiko Wunderlich; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2011-11-11       Impact factor: 4.304

3.  Extracellular matrix protein tenascin-like gene found in human MHC class III region.

Authors:  K Matsumoto; N Ishihara; A Ando; H Inoko; T Ikemura
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 4.  Skin wound healing and scarring: fetal wounds and regenerative restitution.

Authors:  Cecelia C Yates; Patricia Hebda; Alan Wells
Journal:  Birth Defects Res C Embryo Today       Date:  2012-12

5.  Characterization of mouse fibronectin alternative mRNAs reveals an unusual isoform present transiently during liver development.

Authors:  G K Górski; M C Aros; P A Norton
Journal:  Gene Expr       Date:  1996

6.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.

Authors:  P Sriramarao; M A Bourdon
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

7.  TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.

Authors:  A Berndt; H Kosmehl; U Mandel; U Gabler; X Luo; D Celeda; L Zardi; D Katenkamp
Journal:  Histochem J       Date:  1995-12

8.  Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

Authors:  A J Coito; L F Brown; J H Peters; J W Kupiec-Weglinski; L van de Water
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 9.  Cartilage destruction by matrix degradation products.

Authors:  Tadashi Yasuda
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

10.  Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.

Authors:  J L Barnes; R R Hastings; M A De la Garza
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.